SIREN : 812940526
BIOPINSON is a French company founded 10 years ago, specialized in the sector Activités des sociétés holding. Based in CHATILLON-EN-DIOIS (26410), this company of category PME shows in 2024 a revenue of 240 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 240 400 € | 201 600 € | 201 600 € | 201 600 € | 201 600 € | 176 650 € | 146 400 € | 120 000 € | 60 000 € |
| Net income | 3 149 € | 1 924 € | -195 034 € | 52 532 € | 92 220 € | 91 709 € | 76 619 € | 57 958 € | 11 644 € |
| EBITDA | 83 171 € | 80 332 € | 92 717 € | 105 273 € | 98 816 € | 100 817 € | 75 789 € | 51 697 € | 23 601 € |
| Net margin | 1.3% | 1.0% | -96.7% | 26.1% | 45.7% | 51.9% | 52.3% | 48.3% | 19.4% |
In 2024, BIOPINSON achieves revenue of 240 k€. Over the period 2016-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +18.9%. Vs 2023, growth of +19% (202 k€ -> 240 k€). After deducting consumption (0 €), gross margin stands at 240 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 83 k€, representing 34.6% of revenue. Warning negative scissor effect: despite revenue change (+19%), EBITDA varies by +4%, reducing margin by 5.3 pts. This reflects costs rising faster than revenue. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 3 k€, i.e. 1.3% of revenue. This profit can be retained or distributed to shareholders.
240 400 €
240 400 €
83 171 €
83 171 €
3 149 €
34.6%
The debt ratio (= Financial debt / Equity x 100) stands at 79%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 54%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
79.052%
54.346%
-4.127%
-111.229
In 2024, the debt ratio of BIOPINSON (79.05) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of BIOPINSON (54.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2024, the repayment capacity of BIOPINSON (-111.23) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 2696.06. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 41.8x. Operating income very largely covers interest expenses: high safety margin.
2696.057
41.823
In 2024, the liquidity ratio of BIOPINSON (2696.06) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2024, the interest coverage of BIOPINSON (41.8x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 40 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 118 days. Excellent situation: suppliers finance 78 days of the operating cycle (retail model). Overall, WCR represents 1314 days of revenue, i.e. 878 k€ to permanently finance. Over 2016-2024, WCR increased by +917%, requiring additional financing.
877 727 €
40 j
118 j
0 j
1314 j
Based on 54 transactions of similar company sales
in 2024,
the value of BIOPINSON is estimated at
244 482 €
(range 61 044€ - 401 739€).
With an EBITDA of 83 171€, the sector multiple of 4.8x is applied.
The price/revenue ratio is 0.59x
(in line with sector norms).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 54 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare BIOPINSON with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des sociétés holding
The revenue of BIOPINSON in 2024 is 240 k€.
Yes, BIOPINSON generated a net profit of 3 k€ in 2024.
The headquarters of BIOPINSON is located in CHATILLON-EN-DIOIS (26410), in the department Drome.
The tax return of BIOPINSON is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
BIOPINSON operates in the sector Activités des sociétés holding (NAF code 64.20Z). See the 'Sector positioning' section above to compare the company with its competitors.